title: Effect of vigabatrin and gabapentin on phynytoin pharmacokinetics in the dog.
abstract: The study was aimed at investigating whether or not the kinetics of intravenously administered phenytoin (PT) was altered by oral administration of vigabatrin (VGB) or gabapentin (GBP). A group of five beagle dogs were given a daily dose of PT (12 mg/kg, i.v.) for a period of 1 week. On day 8, plasma samples were serially collected over 24 hr. after administration of the PT dose. PT administration was continued with oral supplementary dose of VGB (60 mg/kg) for another week and then plasma samples were collected for analysis of PT levels. The same protocol was followed for the PT (12 mg/kg, i.v.)-GBP (300 mg caps., p.o.) study on a separate group (n = 5) of dogs. Orally administered GBP did not significantly alter the pharmacokinetic parameters of parental PT. VGB, however markedly changed the drug's kinetics as evidenced by a 31% (P = 0.015) reduction in total body clearance (CL) and increase of over 45% in half-life (t1/2), (P = 0.013) and area under the plasma PT concentration-time curve (AUC), (P = 0.044). GBP does not appear to have any pharmacokinetic interaction with PT, while coadministration of VGB and PT results in marked reduction in systemic clearance of the latter in the dog.
authors: Clinical Pharmacy Department, College of Pharmacy King Saud University, P.O. Box 2457, 11451 Riyadh, Saudi Arabia.
authors: K M
authors: KM
authors: Matar
authors: P J
authors: PJ
authors: Nicholls
authors: A
authors: A
authors: Tekle
authors: S A
authors: SA
authors: Bawazir
authors: M I
authors: MI
authors: al-Hassan
mesh_terms: D000085:Acetates / Q000494:pharmacology*; D000588:Amines; D000818:Animals; D000927:Anticonvulsants / Q000493:pharmacokinetics* / Q000494:pharmacology; D003509:Cyclohexanecarboxylic Acids; D004285:Dogs; D004347:Drug Interactions; D000077206:Gabapentin; D008297:Male; D010672:Phenytoin / Q000493:pharmacokinetics*; D020888:Vigabatrin / Q000494:pharmacology*; D005680:gamma-Aminobutyric Acid
chemical_list: D000085:Acetates; D000588:Amines; D000927:Anticonvulsants; D003509:Cyclohexanecarboxylic Acids; D005680:gamma-Aminobutyric Acid; D010672:Phenytoin; D000077206:Gabapentin; D020888:Vigabatrin